Detalles de la búsqueda
1.
Hepatitis delta infection among persons living with HIV in Europe.
Liver Int
; 43(4): 819-828, 2023 04.
Artículo
en Inglés
| MEDLINE | ID: mdl-36625770
2.
Long-Term Study of Hepatitis Delta Virus Infection at Secondary Care Centers: The Impact of Viremia on Liver-Related Outcomes.
Hepatology
; 72(4): 1177-1190, 2020 10.
Artículo
en Inglés
| MEDLINE | ID: mdl-32145073
3.
Clinical Outcomes in Persons Coinfected With Human Immunodeficiency Virus and Hepatitis C Virus: Impact of Hepatitis C Virus Treatment.
Clin Infect Dis
; 70(10): 2131-2140, 2020 05 06.
Artículo
en Inglés
| MEDLINE | ID: mdl-31504296
4.
IL13Rα2 expression identifies tissue-resident IL-22-producing PLZF+ innate T cells in the human liver.
Eur J Immunol
; 48(8): 1329-1335, 2018 08.
Artículo
en Inglés
| MEDLINE | ID: mdl-29677387
5.
The Human NK Cell Response to Yellow Fever Virus 17D Is Primarily Governed by NK Cell Differentiation Independently of NK Cell Education.
J Immunol
; 195(7): 3262-72, 2015 Oct 01.
Artículo
en Inglés
| MEDLINE | ID: mdl-26283480
6.
The future disease burden of hepatitis C virus infection in Sweden and the impact of different treatment strategies.
Scand J Gastroenterol
; 50(2): 233-44, 2015 Feb.
Artículo
en Inglés
| MEDLINE | ID: mdl-25515032
7.
Temporal dynamics of the primary human T cell response to yellow fever virus 17D as it matures from an effector- to a memory-type response.
J Immunol
; 190(5): 2150-8, 2013 Mar 01.
Artículo
en Inglés
| MEDLINE | ID: mdl-23338234
8.
Occasional spontaneous clearance of chronic hepatitis C virus in HIV-infected individuals.
J Hepatol
; 61(4): 957-61, 2014 Oct.
Artículo
en Inglés
| MEDLINE | ID: mdl-24951853
9.
Clinical significance of residual viremia detected by two real-time PCR assays for response-guided therapy of HCV genotype 1 infection.
J Hepatol
; 60(5): 913-9, 2014 May.
Artículo
en Inglés
| MEDLINE | ID: mdl-24424305
10.
High HCV treatment uptake in the Swedish HIV/HCV co-infected cohort.
Scand J Infect Dis
; 46(9): 624-32, 2014 Sep.
Artículo
en Inglés
| MEDLINE | ID: mdl-24984040
11.
Low Risk of Failing Direct-Acting Antivirals in People With Human Immunodeficiency Virus/Hepatitis C Virus From Sub-Saharan Africa or Southeastern Asia: A European Cross-Sectional Study.
Open Forum Infect Dis
; 9(10): ofac508, 2022 Oct.
Artículo
en Inglés
| MEDLINE | ID: mdl-36320198
12.
Expansion of functionally skewed CD56-negative NK cells in chronic hepatitis C virus infection: correlation with outcome of pegylated IFN-alpha and ribavirin treatment.
J Immunol
; 183(10): 6612-8, 2009 Nov 15.
Artículo
en Inglés
| MEDLINE | ID: mdl-19846870
13.
Effectiveness and Safety of Interferon-Free Direct-Acting Antiviral Hepatitis C Virus Therapy in HIV/Hepatitis C Virus Coinfected Individuals: Results From a Pan-European Study.
J Acquir Immune Defic Syndr
; 86(2): 248-257, 2021 02 01.
Artículo
en Inglés
| MEDLINE | ID: mdl-33079903
14.
High levels of chronic immune activation in the T-cell compartments of patients coinfected with hepatitis C virus and human immunodeficiency virus type 1 and on highly active antiretroviral therapy are reverted by alpha interferon and ribavirin treatment.
J Virol
; 83(21): 11407-11, 2009 Nov.
Artículo
en Inglés
| MEDLINE | ID: mdl-19710147
15.
Elevated numbers of Fc gamma RIIIA+ (CD16+) effector CD8 T cells with NK cell-like function in chronic hepatitis C virus infection.
J Immunol
; 181(6): 4219-28, 2008 Sep 15.
Artículo
en Inglés
| MEDLINE | ID: mdl-18768879
16.
IP-10 predicts the first phase decline of HCV RNA and overall viral response to therapy in patients co-infected with chronic hepatitis C virus infection and HIV.
Scand J Infect Dis
; 42(11-12): 896-901, 2010 Dec.
Artículo
en Inglés
| MEDLINE | ID: mdl-20608766
17.
Plasma FABP4 is associated with liver disease recovery during treatment-induced clearance of chronic HCV infection.
Sci Rep
; 10(1): 2081, 2020 02 07.
Artículo
en Inglés
| MEDLINE | ID: mdl-32034167
18.
HCV/HIV co-infection at a large HIV outpatient clinic in Sweden: feasibility and results of hepatitis C treatment.
Scand J Infect Dis
; 41(11-12): 881-5, 2009.
Artículo
en Inglés
| MEDLINE | ID: mdl-19922074
19.
Expansion of CD56- NK cells in chronic HCV/HIV-1 co-infection: reversion by antiviral treatment with pegylated IFNalpha and ribavirin.
Clin Immunol
; 128(1): 46-56, 2008 Jul.
Artículo
en Inglés
| MEDLINE | ID: mdl-18495540
20.
Spontaneous HCV clearance in HCV/HIV-1 coinfection associated with normalized CD4 counts, low level of chronic immune activation and high level of T cell function.
J Clin Virol
; 41(2): 160-3, 2008 Feb.
Artículo
en Inglés
| MEDLINE | ID: mdl-18093872